None | 02 Mar 2009 | Africa Fighting Malaria
A range of antimalarial drugs were procured from private pharmacies, shops and kiosks within the urban and peri-urban areas of Lusaka, Zambia. Semi-quantitative thin-layer chromatography (TLC) and disintegration tests were conducted to measure active pharmaceutical ingredient content against internationally acceptable standards.
Roger Bate | 01 Mar 2009 | Economic Affairs
The Government of India has at last signaled its intention to combat the menace of fake pharmaceuticals. Last October the upper house of the Indian Government passed into law amendments to the Drugs and Cosmetics Act 1940, which create a comprehensive national food and drug authority, replacing the ineffectual structure where responsibility was shared between Centre and States and the villains operated freely in the gaps in between.
Joe De Capua | 26 Feb 2009 | Voice of America
A new study suggests that one of the most important malaria drugs, artemether-lumefantrine, may remain potent well after its shelf-life was thought to expire. The study, published in the Malaria Journal, says the drug used in artemisinin-based therapy could possibly be used years after its listed expiration date.
None | 28 Oct 2008 | Africa Fighting Malaria
Visit the March of Washingtons website at www.marchofwashingtons.org - find out how you can help in the fight against malaria, see pictures from other marches, learn more about treatment for malaria and the prevalence of substandard antimalarial drugs, check out the supporters and Founding Partners, tell us about your March of Washingtons and upload your picture.
Jasson Urbach | 18 Aug 2008 | iafrica.com
In the last week of July the malaria community from the East and Southern Africa regions came together in Lusaka, Zambia for their annual planning and review meeting. This important meeting provides a forum to review the malaria control programmes of each of the 22 countries in the region and this year's specific theme was "Improving Malaria Diagnosis".
None | 01 Jul 2008 | Africa Fighting Malaria
Media coverage of malaria treatment focuses mostly on public sector drug delivery and new formulations of drugs under development. However, most anti-malarial drugs are obtained in the private sector, and few of the widely discussed drugs are actually bought by most Africans. This bulletin is the first in a series of papers discussing some of the less documented issues related to access of anti-malarial drugs in private and public settings.
Richard Tren | 06 Jun 2008 | New York Times
AFM Director Richard Tren writes in the New York Times, "Malaria control requires more than just nets. An associated danger with the grass-roots efforts is that simple but effective marketing messages conceal the fact that the disease is very complex and difficult to control. Along with nets, indoor spraying with insecticides is an essential, but poorly financed, method of malaria control. Improving access to high-quality malaria medicines is crucial, especially with the prospect of drug resistance ever present." This is the goal of the March of Washingtons - raising awareness of and funding for access to good quality malaria drugs.
Carlos Odora | 21 May 2008 | New Vision
Although malaria is preventable and curable, it is reported to claim 320 lives daily in Uganda. Recently, however, efforts to reduce these deaths have improved with more widespread use of insecticide-treated nets, indoor spraying with insecticides and better access to effective new Artemisinin combination medicine. Many people still access medicines from private pharmacies and shops.
Roger Bate | 16 May 2008 | Globe and Mail
New field research shows that a third of anti-malaria drugs collected in six African cities fail at least one quality test, and aid agencies continue to fund untested, substandard drugs. The World Health Organization suggests that one-fifth of the approximately one million children who die every year from malaria die because of substandard and poorly prescribed medicines.
Roger Bate | 06 Feb 2008 | The Daily Times
The World Health Organisation says 30 percent of the world's population lacks access to life-saving medicines because of poor health infrastructure. Activists say prices are the problem and have tried to lower them by browbeating western pharmaceutical companies and encouraging competition by cheaper copycat "generics." Their latest scheme is to subsidise local production in developing countries--with many unintended consequences.